Literature DB >> 8053370

Epidemiology of depression: prevalence, risk factors and treatment situation.

V Lehtinen1, M Joukamaa.   

Abstract

Depending on the way it is defined depression can be seen as a state of mood, as a symptom, as a syndrome or as a clinical diagnosis. Epidemiological studies show that depression is the most common mental disorder in man. Up to 4% of men and 8% of women suffer from a clinically significant depressive disorder, while depressive symptoms are much more common. The occurrence of depression is associated with factors such as age, marital status, social class, and social conditions. In Finland, only one third of persons suffering from depression are actually being treated for their disorder.

Entities:  

Mesh:

Year:  1994        PMID: 8053370     DOI: 10.1111/j.1600-0447.1994.tb05794.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  31 in total

1.  Depression, Smoking, and Ego-Centric Social Network Characteristics in Ohio Appalachian Women.

Authors:  Jeffrey Lam; Bo Lu; Nate Doogan; Tiffany Thomson; Amy Ferketich; Electra D Paskett; Mary Ellen Wewers
Journal:  Rural Ment Health       Date:  2017-01

2.  Mental illness in a rural area: a Norwegian psychiatric epidemiological study.

Authors:  Einar Kringlen; Svenn Torgersen; Victoria Cramer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-05-26       Impact factor: 4.328

3.  Do depressive symptoms affect mothers' reports of child outcomes in children with new-onset epilepsy?

Authors:  Mark A Ferro; William R Avison; M Karen Campbell; Kathy N Speechley
Journal:  Qual Life Res       Date:  2010-05-07       Impact factor: 4.147

Review 4.  Paroxetine. A pharmacoeconomic evaluation of its use in depression.

Authors:  M I Wilde; R Whittington
Journal:  Pharmacoeconomics       Date:  1995-07       Impact factor: 4.981

5.  Genetic and environmental contributions to the relationship between education and anxiety disorders - a twin study.

Authors:  K Tambs; K S Kendler; T Reichborn-Kjennerud; S H Aggen; J R Harris; M C Neale; J M Hettema; J M Sundet; M Battaglia; E Røysamb
Journal:  Acta Psychiatr Scand       Date:  2011-11-24       Impact factor: 6.392

Review 6.  Sertraline. A pharmacoeconomic evaluation of its use in depression.

Authors:  R Davis; M I Wilde
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 7.  Fluoxetine. A pharmacoeconomic review of its use in depression.

Authors:  M I Wilde; P Benfield
Journal:  Pharmacoeconomics       Date:  1998-05       Impact factor: 4.981

8.  Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder.

Authors:  Zengjian Wang; Xiaoyun Wang; Jian Liu; Jun Chen; Xian Liu; Guangning Nie; Kristen Jorgenson; Ki Cheul Sohn; Ruiwang Huang; Ming Liu; Bo Liu; Jian Kong
Journal:  J Psychiatr Res       Date:  2016-09-16       Impact factor: 4.791

9.  Environmental exposures and their genetic or environmental contribution to depression and fatigue: a twin study in Sri Lanka.

Authors:  Harriet A Ball; Sisira H Siribaddana; Athula Sumathipala; Yulia Kovas; Nick Glozier; Peter McGuffin; Matthew Hotopf
Journal:  BMC Psychiatry       Date:  2010-02-02       Impact factor: 3.630

10.  Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder.

Authors:  Edward H Clayton; Tanya L Hanstock; Stephen J Hirneth; Colin J Kable; Manohar L Garg; Philip L Hazell
Journal:  Lipids       Date:  2008-09-10       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.